News
A better way to test new treatments?
A new approach to testing medical treatment options could ensure that more patients get the most beneficial treatment for them - but still yield...
News
Researchers block pathway to cancer cell replication
Research suggests that patients with leukemia sometimes relapse because standard chemotherapy fails to kill the self-renewing leukemia initiating cells, often referred to as cancer...
News
Bristol-Myers Squibb and AstraZeneca expand diabetes alliance
Bristol-Myers Squibb Company and Amylin Pharmaceuticals, Inc. announced that Bristol-Myers Squibb will acquire Amylin for $31.00 per share in cash, pursuant to a cash...
News
FDA grants priority review to the new drug application...
Bayer HealthCare announced that the U.S. Food and Drug Administration (FDA) has granted priority review to the New Drug Application (NDA) filed end of...
News
New compound holds promise for treating Duchenne MD
Scientists at UCLA have identified a new compound that could treat certain types of genetic disorders in muscles. It is a big first step...
News
Roche to streamline research and development activities
Roche site in Nutley to be closed - respective R&D activities to be consolidated in Switzerland and Germany. The planned site consolidation and the...
News
Metformin may lower cancer risk in people with Type...
A commonly prescribed diabetes drug, metformin, reduces the overall cancer risk in people with Type 2 diabetes, a large systematic review study finds. The...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.